Research Update: MED ParentCo L.P. Assigned 'B' Issuer Credit Rating; Outlook Stable; Debt Added In Buyout Also Rated - S&P Global Ratings’ Credit Research

Research Update: MED ParentCo L.P. Assigned 'B' Issuer Credit Rating; Outlook Stable; Debt Added In Buyout Also Rated

Research Update: MED ParentCo L.P. Assigned 'B' Issuer Credit Rating; Outlook Stable; Debt Added In Buyout Also Rated - S&P Global Ratings’ Credit Research
Research Update: MED ParentCo L.P. Assigned 'B' Issuer Credit Rating; Outlook Stable; Debt Added In Buyout Also Rated
Published Jul 17, 2019
7 pages (2847 words) — Published Jul 17, 2019
Price US$ 225.00  |  Buy this Report Now

About This Report

  
Abstract:

Goldman Sachs Merchant Banking Division has agreed to acquire optical retailer CVS Holdings I L.P., operating as MyEyeDr. We are assigning our 'B' issuer credit rating to MED ParentCo L.P., which will become the ultimate parent of CVS Holdings at transaction closing. The issuer credit rating we assigned to MED ParentCo is the same as the existing rating on CVS Holdings, which we will withdraw at transaction close. We are assigning our 'B' issue-level rating and '3' recovery rating to the company's proposed first lien credit facility, which includes a $125 million revolver due 2024 and a $845 million term loan due 2026. We are also assigning our 'CCC+' issue-level rating with a '6' recovery rating to the proposed $360

  
Brief Excerpt:

...- Goldman Sachs Merchant Banking Division has agreed to acquire optical retailer CVS Holdings I L.P., operating as MyEyeDr. - We are assigning our 'B' issuer credit rating to MED ParentCo L.P., which will become the ultimate parent of CVS Holdings at transaction closing. The issuer credit rating we assigned to MED ParentCo is the same as the existing rating on CVS Holdings, which we will withdraw at transaction close. - We are assigning our 'B' issue-level rating and '3' recovery rating to the company's proposed first lien credit facility, which includes a $125 million revolver due 2024 and a $845 million term loan due 2026. We are also assigning our '###+' issue-level rating with a '6' recovery rating to the proposed $360 million second-lien term loan due 2027. - The stable outlook reflects our expectation that MyEyeDr. will improve credit metrics due to profit growth from accretive acquisitions and same-store sales increases....

  
Report Type:

Research Update

Issuer
Sector
Global Issuers
Country
Region
Format:
PDF Adobe Acrobat
Buy Now

S&P Global Ratings’ Credit Research—S&P Global Ratings’ credit research provides analysis on issuers and debt obligations of corporations, states and municipalities, financial institutions, insurance companies and sovereign governments. S&P Global Ratings also offers insight into the credit risk of structured finance deals, providing an independent view of credit risk associated with a growing array of debt-securitized instruments.

About the Author


Cite this Report

  
MLA:
S&P Global Ratings’ Credit Research. "Research Update: MED ParentCo L.P. Assigned 'B' Issuer Credit Rating; Outlook Stable; Debt Added In Buyout Also Rated" Jul 17, 2019. Alacra Store. May 06, 2025. <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-MED-ParentCo-L-P-Assigned-B-Issuer-Credit-Rating-Outlook-Stable-Debt-Added-In-Buyout-Also-Rated-2266183>
  
APA:
S&P Global Ratings’ Credit Research. (). Research Update: MED ParentCo L.P. Assigned 'B' Issuer Credit Rating; Outlook Stable; Debt Added In Buyout Also Rated Jul 17, 2019. New York, NY: Alacra Store. Retrieved May 06, 2025 from <http://www.alacrastore.com/s-and-p-credit-research/Research-Update-MED-ParentCo-L-P-Assigned-B-Issuer-Credit-Rating-Outlook-Stable-Debt-Added-In-Buyout-Also-Rated-2266183>
  
US$ 225.00
$  £  
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research

Search all our Credit Research from one place.